EpiGen Pharmaceuticals, Inc. (EpiGen) is a privately-held clinical stage pharmaceutical company based in Princeton, New Jersey, focused on the development of cardiac reperfusion therapies.

The company was founded with support from the University of Pennsylvania Center for Technology Transfer.